Showing results (311-320 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|August 25, 2000
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomasP A Burch, A M Bernath, T L Cascino, et al.Investigational New Drugs|September 20, 2001
Tetramethylpiperidine-substituted phenazines inhibit the proliferation of intrinsically multidrug resistant carcinoma cell linesE van Niekerk, J F O'Sullivan, G K Jooné, et al.Investigational New Drugs|September 20, 2001
Phase II study of bryostatin 1 in patients with relapsed multiple myelomaM L Varterasian, P A Pemberton, K Hulburd, et al.Investigational New Drugs|September 20, 2001
Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulvenA L Woynarowska BAHigdon, R M Muñoz, P Bushong, et al.Investigational New Drugs|September 20, 2001
Gene expression profiling of exposure to TZT-1027, a novel microtubule-interfering agent, in non-small cell lung cancer PC-14 cells and astrocytesT Natsume, T Nakamura, Y Koh, et al.Investigational New Drugs|September 20, 2001
Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II studyW E Samlowski, H Gundacker, J P Kuebler, et al.Investigational New Drugs|February 9, 2000
Tyrosine kinase inhibitors in preclinical developmentM L Levitt, P P KotyInvestigational New Drugs|February 9, 2000
Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathwayD W EndPageof 372